Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 15/3/2021
SIETES contiene 93212 citas

 1 a 9 de 9 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Macdougall IC, Provenzano R, Sharma A, Spinowitz BS, Schmidt RJ, Pergola PE, Zabaneh RI, Tong-Starksen S, Mayo MR, Tang H, Polu KR, Duliege AM, Fishbane S, PEARL Study Groups. Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis. N Engl J Med 2013;368:320-32. [Ref.ID 94806]
2.Tiene citas relacionadas Cita con resumen
Fishbane S, Schiller B, Locatelli F, Covic AC, Provenzano R, Wiecek A, Levin NW, Kaplan M, Macdougall IC, Francisco C, Mayo MR, Polu KR, Duilege A-M, Besarab A, for the EMERALD Study Groups. Peginesatide in patients with anemia undergoing hemodialysis. N Engl J Med 2013;368:307-19. [Ref.ID 94805]
3.Tiene citas relacionadas Cita con resumen
Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Sherhag A, for the CREATE Investigators. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071-84. [Ref.ID 78523]
4. Cita con resumen
Macdougall IC, Eckardt KU. Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia. Lancet 2006;368:947-53. [Ref.ID 77990]
5.Tiene citas relacionadas
Macdougall IC. Darbepoetin alfa: viewpoint. Drugs 2001;61:2106. [Ref.ID 59700]
Macdougall IC. Adverse reactions profile: 4. Erythropoietin in chronic renal failure. Prescr J 1992;32:40-4. [Ref.ID 17063]
Macdougall IC, Roberts D E, Coles GA, Williams JD. Clinical pharmacokinetics of epoetin (recombinant human erythropoietin). Clin Pharmacokinet 1991;20:99-113. [Ref.ID 16227]
Macdougall IC, Hutton RD, Cavill I, Coles GA, Williams JD. Treating renal anemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm. BMJ 1990;300:655-9. [Ref.ID 13885]
Macdougall IC, Lewis NP, Saunders MJ, Cochlin DL, Davies ME, Hutton RD, Fox KAA, Coles GA, Williams JD. Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin. Lancet 1990;335:489-93. [Ref.ID 12736]
Seleccionar todas
 1 a 9 de 9